← Browse by Condition
Medical Condition

head neck squamous cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT07448727
Recruiting

Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

Enrollment
25 pts
Location
Italy
Sponsor
University of Rome Tor Vergata
View Trial →